ARGINASE INHIBITORS AND METHODS OF USE THEREOF
Disclosed are compounds of formula (Ib) or (Vc), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ib) or (Vc) and methods of using the same for treating cancer, respiratory inflammatory disease, and inhibiting arginase; wherein R is -H or -C...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; hun |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SIMPSON, Iain KAWATKAR, Sameer FINLAY, Maurice Raymond Verschoyle MLYNARSKI, Scott Nathan GREBE, Tyler |
| description | Disclosed are compounds of formula (Ib) or (Vc), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ib) or (Vc) and methods of using the same for treating cancer, respiratory inflammatory disease, and inhibiting arginase; wherein R is -H or -C(O)CH(R1a)NHR1b; and R1a is selected from -H, -(C1-C4) alkyl and CH2OR1c; R1b is -H; or alternatively, R1a and R1b, together with the atom to which they are attached, form a 5-membered heterocyclic ring; and R1c is H or -CH3. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE062968TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE062968TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE062968TT23</originalsourceid><addsrcrecordid>eNrjZNBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgFyoZ4uAa5-rvxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4j1BXAzMjSzOLkBAjY2LUAADjIiZC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARGINASE INHIBITORS AND METHODS OF USE THEREOF</title><source>esp@cenet</source><creator>SIMPSON, Iain ; KAWATKAR, Sameer ; FINLAY, Maurice Raymond Verschoyle ; MLYNARSKI, Scott Nathan ; GREBE, Tyler</creator><creatorcontrib>SIMPSON, Iain ; KAWATKAR, Sameer ; FINLAY, Maurice Raymond Verschoyle ; MLYNARSKI, Scott Nathan ; GREBE, Tyler</creatorcontrib><description>Disclosed are compounds of formula (Ib) or (Vc), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ib) or (Vc) and methods of using the same for treating cancer, respiratory inflammatory disease, and inhibiting arginase; wherein R is -H or -C(O)CH(R1a)NHR1b; and R1a is selected from -H, -(C1-C4) alkyl and CH2OR1c; R1b is -H; or alternatively, R1a and R1b, together with the atom to which they are attached, form a 5-membered heterocyclic ring; and R1c is H or -CH3.</description><language>eng ; hun</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231228&DB=EPODOC&CC=HU&NR=E062968T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231228&DB=EPODOC&CC=HU&NR=E062968T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SIMPSON, Iain</creatorcontrib><creatorcontrib>KAWATKAR, Sameer</creatorcontrib><creatorcontrib>FINLAY, Maurice Raymond Verschoyle</creatorcontrib><creatorcontrib>MLYNARSKI, Scott Nathan</creatorcontrib><creatorcontrib>GREBE, Tyler</creatorcontrib><title>ARGINASE INHIBITORS AND METHODS OF USE THEREOF</title><description>Disclosed are compounds of formula (Ib) or (Vc), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ib) or (Vc) and methods of using the same for treating cancer, respiratory inflammatory disease, and inhibiting arginase; wherein R is -H or -C(O)CH(R1a)NHR1b; and R1a is selected from -H, -(C1-C4) alkyl and CH2OR1c; R1b is -H; or alternatively, R1a and R1b, together with the atom to which they are attached, form a 5-membered heterocyclic ring; and R1c is H or -CH3.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgFyoZ4uAa5-rvxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4j1BXAzMjSzOLkBAjY2LUAADjIiZC</recordid><startdate>20231228</startdate><enddate>20231228</enddate><creator>SIMPSON, Iain</creator><creator>KAWATKAR, Sameer</creator><creator>FINLAY, Maurice Raymond Verschoyle</creator><creator>MLYNARSKI, Scott Nathan</creator><creator>GREBE, Tyler</creator><scope>EVB</scope></search><sort><creationdate>20231228</creationdate><title>ARGINASE INHIBITORS AND METHODS OF USE THEREOF</title><author>SIMPSON, Iain ; KAWATKAR, Sameer ; FINLAY, Maurice Raymond Verschoyle ; MLYNARSKI, Scott Nathan ; GREBE, Tyler</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE062968TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2023</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SIMPSON, Iain</creatorcontrib><creatorcontrib>KAWATKAR, Sameer</creatorcontrib><creatorcontrib>FINLAY, Maurice Raymond Verschoyle</creatorcontrib><creatorcontrib>MLYNARSKI, Scott Nathan</creatorcontrib><creatorcontrib>GREBE, Tyler</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SIMPSON, Iain</au><au>KAWATKAR, Sameer</au><au>FINLAY, Maurice Raymond Verschoyle</au><au>MLYNARSKI, Scott Nathan</au><au>GREBE, Tyler</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARGINASE INHIBITORS AND METHODS OF USE THEREOF</title><date>2023-12-28</date><risdate>2023</risdate><abstract>Disclosed are compounds of formula (Ib) or (Vc), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ib) or (Vc) and methods of using the same for treating cancer, respiratory inflammatory disease, and inhibiting arginase; wherein R is -H or -C(O)CH(R1a)NHR1b; and R1a is selected from -H, -(C1-C4) alkyl and CH2OR1c; R1b is -H; or alternatively, R1a and R1b, together with the atom to which they are attached, form a 5-membered heterocyclic ring; and R1c is H or -CH3.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; hun |
| recordid | cdi_epo_espacenet_HUE062968TT2 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ARGINASE INHIBITORS AND METHODS OF USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A39%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SIMPSON,%20Iain&rft.date=2023-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE062968TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |